Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ET-743: a novel agent with activity in soft tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Ranchère D, Boyle H, Blay JY. Fayette J, et al. Among authors: ranchere d. Oncologist. 2005 Nov-Dec;10(10):827-32. doi: 10.1634/theoncologist.10-10-827. Oncologist. 2005. PMID: 16314293 Free article. Review.
ET-743: a novel agent with activity in soft-tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Boyle H, Méeus P, Decouvelaere AV, Thiesse P, Sunyach MP, Ranchère D, Blay JY. Fayette J, et al. Among authors: ranchere d. Curr Opin Oncol. 2006 Jul;18(4):347-53. doi: 10.1097/01.cco.0000228740.70379.3f. Curr Opin Oncol. 2006. PMID: 16721129 Review.
Emerging drugs for the treatment of soft tissue sarcomas.
Cassier PA, Dufresne A, Fayette J, Alberti L, Ranchere D, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: ranchere d. Expert Opin Emerg Drugs. 2007 Mar;12(1):139-53. doi: 10.1517/14728214.12.1.139. Expert Opin Emerg Drugs. 2007. PMID: 17355219 Review.
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.
Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Méeus P, Sunyach MP, Vaz G, Ray-Coquard I, Ranchère D, Decouvelaere AV, Alberti L, Pérol D, Blay JY. Fayette J, et al. Among authors: ranchere d. Anticancer Drugs. 2010 Jan;21(1):113-9. doi: 10.1097/CAD.0b013e328333057b. Anticancer Drugs. 2010. PMID: 19887935 Clinical Trial.
[Neoadjuvant chemotherapy in sarcoma].
Blay JY, Bonvalot S, Fayette J, Stockle E, Ray-Coquard I, Coindre JM, Duffaud F, Taieb S, Sunyach MP, Ranchere D, Meeus P, Le Cesne A, Bui BN. Blay JY, et al. Among authors: ranchere d. Bull Cancer. 2006 Nov;93(11):1093-8. Bull Cancer. 2006. PMID: 17145578 Free article. Review. French.
Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Cassier PA, Dufresne A, Arifi S, El Sayadi H, Labidi I, Ray-Coquard I, Tabone S, Méeus P, Ranchère D, Sunyach MP, Decouvelaere AV, Alberti L, Blay JY. Cassier PA, et al. Among authors: ranchere d. Expert Opin Pharmacother. 2008 May;9(7):1211-22. doi: 10.1517/14656566.9.7.1211. Expert Opin Pharmacother. 2008. PMID: 18422477 Review.
[Targeted therapy of sarcomas].
Cassier PA, Dufresne A, El Sayadi H, Pissaloux D, Alberti L, Decouvelaere AV, Ranchere D, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: ranchere d. Bull Cancer. 2008 Oct;95(10):963-74. doi: 10.1684/bdc.2008.0730. Bull Cancer. 2008. PMID: 19004727 French.
[Imatinib and solid tumours].
Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P. Arifi S, et al. Among authors: ranchere d. Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557. Bull Cancer. 2008. PMID: 18230575 Review. French.
55 results